SCHEMBL16511786

SCHEMBL16511786

CS(=O)(=O)C(CCNC(=O)c1ccc(-c2cccs2)s1)C(=O)NO

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.56
▸ CTSB P07858 1/20 0.47
▸ CTSS P25774 1/20 0.47
▸ CTSK P43235 1/20 0.47
▸ CTSF Q9UBX1 1/20 0.47
▸ KDM4E B2RXH2 5/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ GAA P10253 4/20 0.45
▸ LMNA P02545 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ GLA P06280 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RAB9A P51151 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ HPGD P15428 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16511789 0.99 HDAC1 (0.55) HDAC1CTSBCTSSCTSKCTSF
SCHEMBL17921133 0.89 HDAC1 (0.52) HDAC1CTSBCTSSCTSKCTSF
SCHEMBL17921141 0.88 HDAC1 (0.51) HDAC1CTSBCTSSCTSKCTSF
SCHEMBL16511766 0.86 NAMPT (0.44) HDAC1KDM4EALDH1A1GAALMNA
SCHEMBL16512631 0.86 RXFP1 (0.48) HDAC1KDM4EALDH1A1GAAL3MBTL1
SCHEMBL16511408 0.82 CTSB (0.47) HDAC1CTSBCTSSKDM4EALDH1A1
SCHEMBL16512687 0.79 HDAC1 (0.54) HDAC1CTSBCTSSCTSKCTSF
SCHEMBL16511441 0.79 HDAC1 (0.44) HDAC1CTSBCTSSCTSKCTSF
SCHEMBL16511341 0.79 HDAC1 (0.44) HDAC1CTSBCTSSCTSKCTSF
SCHEMBL16512634 0.78 HDAC1 (0.43) HDAC1CTSBCTSSCTSKCTSF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10189786-B2 Antibacterial compounds DUKE UNIVERSITY (US) 2019-01-29 — — US disclosed
US-20160200673-A1 Antibacterial Compounds DUKE UNIVERSITY 2016-07-14 — — US disclosed
US-20160200673-A1 Antibacterial Compounds DUKE UNIVERSITY 2016-07-14 — — US disclosed
WO-2015024021-A2 ANTIBACTERIAL COMPOUNDS DUKE UNIVERSITY (US) 2015-02-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189786-B2 Antibacterial compounds Q6ZSR9, MRPL21, XDH HDAC1 754/4885CTSB 718/4885CTSS 627/4885
US-20160200673-A1 Antibacterial Compounds Q6ZSR9, MRPL21, XDH HDAC1 754/4885CTSB 718/4885CTSS 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback